Our Latest Plans

  • US Premium data will be available to free users until March 31, 2004.
    Thereafter, all free users will have access to Premium data, delayed by 18 hours.
    Early US subscribers, some of whom have waited almost 2 years, have been offered an extended free trial until June 30, 2004.
  • It is no longer viable to maintain separate raw US or ASX data because of the additional load on the database. Free users will still be able to study technical analysis and test strategies learnt on the Trading Guide (formerly the Easy Guide) and Chart Forum using delayed data.
  • In response to a number of requests, we will offer members the opportunity to subscribe for the Daily Trading Diary and Incredible Charts Premium data separately at $180 (AUD) or $270 (AUD) for the full service. Some development work is required, so this may take a month or two.
  • US subscriptions will be $120 and $180 (USD). Exchange rates may fluctuate but we undertake to maintain stable pricing in both markets.
We will appreciate feedback and suggestions on the Chart Forum.

Trading Diary
January 7, 2004

These extracts from my daily trading diary are for educational purposes and should not be interpreted as investment advice. Full terms and conditions can be found at Terms of Use .

The Dow Industrial Average eased slightly, closing at 10529. Buying support is still evident with a long tail and higher volume.
The intermediate trend is up.
The primary trend is up. A fall below support at 9600 will signal reversal.


The Nasdaq Composite rallied 20 points to close at 2077 on strong volume.
The intermediate trend is up. Resistance is at 2060 to 2100.
The primary trend is up. A fall below support at 1640 will signal reversal.


The S&P 500 made a false break below yesterday's low before rallying to close strongly at 1126.
The intermediate trend is up. The next resistance level is at 1175.
Short-term: Bullish if the S&P500 is above 1124 (Tuesday's high). Bearish below 1118 (Tuesday's low).

The primary trend is up. A fall below 960 will signal reversal.
Intermediate: Bullish above 1124.
Long-term: Bullish above 960.


The Chartcraft NYSE Bullish % Indicator continues to make new highs, reaching 85.26% (January 7).

Credit crunch?
Credit card delinquencies are at a record high of 4.09%.

Treasury yields
The yield on 10-year treasury notes slipped to 4.24%.
The intermediate trend is uncertain. Support is at 4.00% and resistance at 4.50%.
The primary trend is up.

New York (23.37): Spot gold is almost unchanged at $420.20.
The intermediate trend is up.
The primary trend is up. Expect support at 415.

ASX Australia
The All Ordinaries retreated to close at 3310 after yesterday's marginal break above resistance [b]. The close half-way down yesterday's strong up candle signals that the market is uncomfortable with higher prices, confirmed by higher volume. Short-term support is at 3310, the high of [a]. A fall below this level will indicate a loss of momentum, but if price respects the new support level, we may see a strong surge as institutional buyers return from their holidays.

MACD (26,12,9) is above its signal line; Slow Stochastic (20,3,3) is below.
Short-term: Bullish above today's high of 3325.

The All Ords is below its long-term trendline, signaling weakness. The primary trend is up but will reverse if there is a fall below 3160 (the October 1 low). Twiggs Money Flow (100) has leveled out but is still bearish after a large divergence.
Intermediate term: Bullish above 3325. Bearish below 3160.
Long-term: Bearish below 3160.

Understanding the Trading Diary has been expanded to offer further assistance to readers, including directions on how to search the archives.

Colin Twiggs

Humility leads to strength and not to weakness. 
It is the highest form of self-respect
to admit mistakes and to make amends for them. 

John (Jay) McCloy.

Individual Stocks
Analysis of individual stocks will resume on Monday, January 12th.

Back Issues
You can now view back issues at the Daily Trading Diary Archives.

Back Issues
Access the Trading Diary Archives.